OrthoPathways Group announced Bio-Aug FX, an instrument designed to extract stem cells from a patient's bone and then inject the stem cells in a different location, according to a company news release.
Spinal Tech
NovaBone received FDA approval for the NovaBone Putty MIS delivery system for minimally invasive orthopedic surgery, according to a company news release.
K2M, a spinal device company, launched the VIKOS cervical allograft system, the company's first biologics product, according to a company news release.
TranS1, a medical device company focused on solutions for degenerative spine conditions, promoted Stephen Ainsworth, PhD, to the vice president of research and development position, according to a company news release.
RSB Spine received FDA clearance for an additional product code associated with the InterPlate L-Ti, according to a company news release.
Advertisement
Wenzel Spine received FDA 510(k) clearance to market the VariLift expandable interbody fusion system for stand-alone use, according to a company news release.
ArthroCare, an Austin, Texas-based surgical instrument manufacturer, received FDA clearance for the Parallax Contour vertebral augmentation device used to create a void in the vertebral body, according to a company news release.
The U.S. bone graft substitute market will reach $2.3 billion by 2015, a result of the adoption of new growth factors and improved features of newer products, according to a release from the Millennium Research Group.
The Food and Drug Administration issued 32 orthopedic- and spine-related 510(k) clearances in August, according to an FDA report.
Tecomet, a contract manufacturer for the orthopedic, trauma and spinal implant market, announced the opening of LaunchQuick, a full-service rapid prototyping center, according to a company news release.